跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dapazin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Dapazin
Approved
STANDARD
Dapazin
Ajanta Pharma Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b79e10472875553a
Company
Ajanta Pharma Limited
Type
Standard
Approval Details
Approval Id
b79e10472875553a
Drug Approval Philippines Name
Dapazin
Product Name
Dapazin
Registration Number
DR-XY49139
Brand Name
Dapazin
Generic Name
Dapagliflozin
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg
Manufacturer
Ajanta Pharma Limited
Importer
Ajanta Pharma Philippines Inc.
Distributor
Ajanta Pharma Philippines Inc.
Company Detail Path
/organization/ajanta-pharma-limited
Issuance Date
26 July 2024
Expiry Date
26 July 2029
Pharmacologic Category
Blood Glucose Lowering Drug (Sodium-glucose co-transporter 2 (SGLT2) inhibitor).
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b79e10472875553a
Type
Standard
Back to Philippines FDA Approvals